The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Abbott Laboratories (Pakistan) Pretax Margin % Related Terms
Abbott Laboratories (Pakistan) Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KAR:ABOT vs ZTS, UTHR, VTRS: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Abbott Laboratories (Pakistan)'s Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abbott Laboratories (Pakistan) Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Abbott Laboratories (Pakistan)'s Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Abbott Laboratories (Pakistan)'s Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abbott Laboratories (Pakistan) (KAR:ABOT) has a Pretax Margin % of 18.59% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Abbott Laboratories (Pakistan) and its competitors. This is 15% above median its historical median of 16.16. Over the past decade, Abbott Laboratories (Pakistan)'s Pretax Margin % has ranged from 4.67 to 23.89. According to the industry distribution chart, Abbott Laboratories (Pakistan) ranks #205 out of 953 companies in the Drug Manufacturers industry, placing it in the top 21.5%.
Is Abbott Laboratories (Pakistan)'s Pretax Margin % too high?
Abbott Laboratories (Pakistan)'s current Pretax Margin % of 18.59% is 15% above median its 10-year median of 16.16. Over the past 10 years, this metric has ranged from a low of 4.67 to a high of 23.89. The Drug Manufacturers industry median Pretax Margin % is 7.30. Abbott Laboratories (Pakistan)'s value of 18.59% is 154.7% above this industry median. Based on the distribution chart, Abbott Laboratories (Pakistan) ranks #205 out of 953 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Abbott Laboratories (Pakistan) has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories (Pakistan)'s Pretax Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Abbott Laboratories (Pakistan) ranks #205 out of 953 companies for Pretax Margin %. This places Abbott Laboratories (Pakistan) in the top 22% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 7.30. Abbott Laboratories (Pakistan)'s value of 18.59% is 154.7% above this benchmark. Historically, Abbott Laboratories (Pakistan)'s own Pretax Margin % has ranged from 4.67 to 23.89 over the past decade. While the company's 10-year median is 16.16 vs. the industry median of 7.30, Abbott Laboratories (Pakistan) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.30, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Abbott Laboratories (Pakistan)'s current Pretax Margin % of 18.59% is 154.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Abbott Laboratories (Pakistan) and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Abbott Laboratories (Pakistan)'s current Pretax Margin % is 18.59%, which is 15% above median its own 10-year median of 16.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories (Pakistan) stock overvalued right now?
Based on GuruFocus' analysis, Abbott Laboratories (Pakistan) (KAR:ABOT) is currently considered Fairly Valued. The stock's GF Value™ is ₨1,003.35, compared to a current price of ₨995.32 — trading 0.8% below its estimated fair value. The current Pretax Margin % is 18.59%, which is 15% above median its 10-year median of 16.16 and 154.7% above the Drug Manufacturers industry median of 7.30. Abbott Laboratories (Pakistan)'s overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Abbott Laboratories (Pakistan) (KAR:ABOT), the current Pretax Margin % is 18.59% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Abbott Laboratories (Pakistan) (KAR:ABOT) Overvalued in 2026?
Based on GuruFocus' analysis, Abbott Laboratories (Pakistan) stock appears to be undervalued.
The current stock price of ₨995.32 is trading 0.8% below its estimated GF Value™ of ₨1,003.35.
GuruFocus considers Abbott Laboratories (Pakistan) to be Fairly Valued.
Key valuation signals for KAR:ABOT:
Pretax Margin %: 18.59% (15% above median its 10-year median of 16.16)
GF Value™: ₨1,003.35 vs. price of ₨995.32 (0.8% below fair value)
Industry Position: 154.7% above the Drug Manufacturers median (#205 of 953)
No single metric tells the full story. See the KAR:ABOT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Abbott Laboratories (Pakistan) Business Description
Abbott Laboratories (Pakistan) Ltd manufactures, imports, and markets research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. The company's Brands include Duphaston, Brufen, Surbex Z, Arinac, Glucerna, Pediasure, and Ensure.
77GF Score
Get the complete analysis for KAR:ABOT
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KAR:ABOT has been successfully added to your 
